Delaware Judge Allows R1 RCM Acquisition Suit
A court ruling denies a motion to dismiss legal challenges regarding a $9 billion corporate acquisition.
Updated on Oct. 28, 2026 in Healthcare

Live Poll
Should large corporations be allowed to restrict legal challenges to their acquisition deals?
A Delaware judge has denied a motion to dismiss a legal challenge against the $9 billion acquisition of R1 RCM Inc. by affiliates of TowerBrook Capital Partners LP and Ascension Health Alliance.
Why it matters
The ruling marks the first judicial interpretation of new dealmaking safe harbors for insider conflicts of interest introduced in a 2025 overhaul of state corporate law.
The litigation targets a $9 billion acquisition involving R1 RCM Inc. and an affiliate of TowerBrook Capital Partners LP and Ascension Health Alliance. The joint entity holds the power to nominate a majority of the board of directors for R1 RCM Inc.
The players
J. Travis Laster
He is a Vice Chancellor of the Delaware Court of Chancery who issued the ruling regarding the acquisition litigation.
R1 RCM Inc.
This is the company currently involved in a $9 billion acquisition that is being challenged in Delaware court.
TowerBrook Capital Partners LP
This is an investment firm whose affiliate is involved in the acquisition of R1 RCM Inc.
Ascension Health Alliance
This is a major healthcare organization whose affiliate is involved in the R1 RCM Inc. acquisition.
The details
Vice Chancellor J. Travis Laster allowed a group of funds to proceed with their legal challenge, rejecting the defendants' attempt to utilize new safe harbor provisions for insider conflicts. The case scrutinizes whether these specific corporate law amendments protect the acquisition structure involved in the deal.
Timeline
2025: Delaware enacted a major corporate overhaul.
October 28, 2026: A Delaware judge issued the ruling on the litigation.
Market Landscape
This case represents the first judicial construction of the 2025 Delaware corporate law overhaul regarding insider conflicts of interest. The ruling shifts the competitive environment by narrowing the application of new dealmaking safe harbors for corporate entities.
This ruling impacts shareholders and corporate entities by establishing legal precedents for how future acquisitions involving insider conflicts are processed. It signals increased judicial scrutiny for major deals that rely on new statutory protections for boards of directors.
The takeaway
The court's decision suggests that new corporate law safe harbors are not absolute shields against investor challenges. Stakeholders should note that litigation risk remains a significant factor for companies relying on recent statutory changes to govern board-level conflict resolution.
Further reading
For more on industry oversight, see Healthcare.
Source note: This article includes information reported by Bloomberglaw.
Live Poll
Should large corporations be allowed to restrict legal challenges to their acquisition deals?










